Stryker saw year-over-year revenue growth in the second quarter of 2025, according to financial results posted July 31.
Six things to know:
1. Quarterly revenue reached $6 billion, an 11.1% increase year over year.
2. Orthopedic sales grew 2% year over year to $2.2 billion, and med-surg and neurotechnology sales grew 17.3% to $3.8 billion.
3. Hip sales increased 8.9% year over year to $466 million, and knees grew 6.3% to $640 million.
4. Spine implant sales were $5 million. In the first quarter Stryker completed the sale of its U.S. spine business to Viscogliosi Brothers.
5. Stryker operated with net earnings of $884 million. That’s an increase of 7.2% year over year.
6. For the first half of 2025 Stryker made $11.9 billion, an increase of 11.5% compared to the same period in 2024.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
